Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 64% ± 17% | |
brain | 21 studies | 59% ± 19% | |
lung | 20 studies | 69% ± 21% | |
intestine | 14 studies | 64% ± 23% | |
eye | 12 studies | 74% ± 20% | |
liver | 10 studies | 60% ± 29% | |
kidney | 10 studies | 70% ± 23% | |
bone marrow | 7 studies | 49% ± 27% | |
lymph node | 7 studies | 73% ± 22% | |
uterus | 6 studies | 81% ± 17% | |
pancreas | 5 studies | 78% ± 23% | |
heart | 5 studies | 32% ± 15% | |
adipose | 5 studies | 41% ± 16% | |
prostate | 5 studies | 70% ± 33% | |
placenta | 4 studies | 77% ± 31% | |
skin | 4 studies | 68% ± 16% | |
breast | 4 studies | 89% ± 3% | |
ovary | 3 studies | 77% ± 14% | |
adrenal gland | 3 studies | 73% ± 22% | |
esophagus | 3 studies | 63% ± 23% | |
stomach | 3 studies | 45% ± 11% | |
thymus | 3 studies | 82% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 87082.73 | 2641 / 2642 | 100% | 743.12 | 705 / 705 |
bladder | 100% | 56300.86 | 21 / 21 | 100% | 828.75 | 503 / 504 |
prostate | 100% | 39085.13 | 245 / 245 | 100% | 705.92 | 501 / 502 |
esophagus | 100% | 40626.90 | 1442 / 1445 | 100% | 925.72 | 183 / 183 |
ovary | 100% | 56188.26 | 180 / 180 | 100% | 575.82 | 429 / 430 |
breast | 100% | 40392.08 | 459 / 459 | 100% | 1134.65 | 1115 / 1118 |
intestine | 100% | 41920.69 | 966 / 966 | 99% | 792.01 | 524 / 527 |
uterus | 99% | 41434.64 | 169 / 170 | 100% | 871.56 | 459 / 459 |
lung | 99% | 69644.29 | 575 / 578 | 100% | 799.47 | 1154 / 1155 |
stomach | 99% | 40161.60 | 357 / 359 | 100% | 723.89 | 285 / 286 |
thymus | 100% | 43055.66 | 652 / 653 | 99% | 499.47 | 596 / 605 |
adrenal gland | 100% | 73153.89 | 258 / 258 | 97% | 670.32 | 224 / 230 |
skin | 100% | 46344.94 | 1802 / 1809 | 98% | 996.80 | 461 / 472 |
kidney | 100% | 58469.42 | 89 / 89 | 96% | 447.55 | 866 / 901 |
pancreas | 97% | 25817.49 | 318 / 328 | 99% | 691.25 | 176 / 178 |
liver | 95% | 34137.80 | 214 / 226 | 97% | 428.49 | 392 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 726.27 | 29 / 29 |
spleen | 100% | 36823.45 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 723.25 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 302.88 | 1 / 1 |
adipose | 100% | 50482.88 | 1202 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 39124.42 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 43866.93 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 52563.05 | 817 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 560.78 | 75 / 80 |
peripheral blood | 72% | 40552.93 | 671 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006986 | Biological process | response to unfolded protein |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0003009 | Biological process | skeletal muscle contraction |
GO_0009651 | Biological process | response to salt stress |
GO_0001764 | Biological process | neuron migration |
GO_1905323 | Biological process | telomerase holoenzyme complex assembly |
GO_0050821 | Biological process | protein stabilization |
GO_0045040 | Biological process | protein insertion into mitochondrial outer membrane |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0009408 | Biological process | response to heat |
GO_1902949 | Biological process | positive regulation of tau-protein kinase activity |
GO_0032880 | Biological process | regulation of protein localization |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0006839 | Biological process | mitochondrial transport |
GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO_0031396 | Biological process | regulation of protein ubiquitination |
GO_0051131 | Biological process | chaperone-mediated protein complex assembly |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0042220 | Biological process | response to cocaine |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0061684 | Biological process | chaperone-mediated autophagy |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0046677 | Biological process | response to antibiotic |
GO_0043254 | Biological process | regulation of protein-containing complex assembly |
GO_0007004 | Biological process | telomere maintenance via telomerase |
GO_0034605 | Biological process | cellular response to heat |
GO_0043627 | Biological process | response to estrogen |
GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
GO_0043335 | Biological process | protein unfolding |
GO_0006457 | Biological process | protein folding |
GO_0098586 | Biological process | cellular response to virus |
GO_0009409 | Biological process | response to cold |
GO_0010659 | Biological process | cardiac muscle cell apoptotic process |
GO_0042026 | Biological process | protein refolding |
GO_0002218 | Biological process | activation of innate immune response |
GO_0032273 | Biological process | positive regulation of protein polymerization |
GO_0045793 | Biological process | positive regulation of cell size |
GO_0060452 | Biological process | positive regulation of cardiac muscle contraction |
GO_0097226 | Cellular component | sperm mitochondrial sheath |
GO_0043025 | Cellular component | neuronal cell body |
GO_0009986 | Cellular component | cell surface |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0097524 | Cellular component | sperm plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0044294 | Cellular component | dendritic growth cone |
GO_0044295 | Cellular component | axonal growth cone |
GO_0005737 | Cellular component | cytoplasm |
GO_0031526 | Cellular component | brush border membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0043209 | Cellular component | myelin sheath |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0071682 | Cellular component | endocytic vesicle lumen |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005829 | Cellular component | cytosol |
GO_0042470 | Cellular component | melanosome |
GO_0051020 | Molecular function | GTPase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0051022 | Molecular function | Rho GDP-dissociation inhibitor binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0032564 | Molecular function | dATP binding |
GO_0005524 | Molecular function | ATP binding |
GO_0048156 | Molecular function | tau protein binding |
GO_0030911 | Molecular function | TPR domain binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0023026 | Molecular function | MHC class II protein complex binding |
GO_0042826 | Molecular function | histone deacetylase binding |
GO_0070182 | Molecular function | DNA polymerase binding |
GO_0017098 | Molecular function | sulfonylurea receptor binding |
GO_0003729 | Molecular function | mRNA binding |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
GO_0005525 | Molecular function | GTP binding |
GO_0002134 | Molecular function | UTP binding |
GO_0002135 | Molecular function | CTP binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0030235 | Molecular function | nitric-oxide synthase regulator activity |
GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
GO_0097718 | Molecular function | disordered domain specific binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | HSP90AA1 |
Protein name | Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38) Heat shock protein 90 alpha family class A member 1 HSP90AA1 protein |
Synonyms | HSP90A HSPCA HSPC1 |
Description | FUNCTION: Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function . Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself . Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle . Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 . Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels . In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment . Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression . Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes . Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation . Mediates the association of TOMM70 with IRF3 or TBK1 in mitochondrial outer membrane which promotes host antiviral response . .; FUNCTION: (Microbial infection) Seems to interfere with N.meningitidis NadA-mediated invasion of human cells. Decreasing HSP90 levels increases adhesion and entry of E.coli expressing NadA into human Chang cells; increasing its levels leads to decreased adhesion and invasion. . |
Accessions | Q8TBA7 ENST00000553585.5 ENST00000334701.11 [P07900-2] ENST00000216281.13 [P07900-1] P07900 A0A0U1RR69 ENST00000557234.1 Q2VPJ6 H0YJF5 ENST00000554401.1 Q96HX7 ENST00000558600.1 G3V2J8 G3V592 |